Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
14.34
+0.89 (6.62%)
At close: Aug 24, 2026, 4:00 PM EDT
14.61
+0.27 (1.86%)
Pre-market: Aug 25, 2026, 6:03 AM EDT

ARCT Revenue

Arcturus Therapeutics Holdings had revenue of $2.96M in the quarter ending June 30, 2026, a decrease of -89.54%. This brings the company's revenue in the last twelve months to $29.37M, down -75.95% year-over-year. In the year 2025, Arcturus Therapeutics Holdings had annual revenue of $82.03M, down -46.14%.

Revenue (ttm)
$29.37M
Revenue Growth
-75.95%
P/S Ratio
13.88
Revenue / Employee
$264,577
Employees
111
Market Cap
407.59M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202582.03M-70.28M-46.14%
Dec 31, 2024152.31M-14.49M-8.69%
Dec 31, 2023166.80M-39.20M-19.03%
Dec 31, 2022206.00M193.64M1,566.79%
Dec 31, 202112.36M2.82M29.56%
Dec 31, 20209.54M-11.25M-54.12%
Dec 31, 201920.79M5.04M31.97%
Dec 31, 201815.75M2.76M21.20%
Dec 31, 201713.00M-7.38M-36.23%
Dec 31, 201620.38M14.24M232.06%
Dec 31, 20156.14M--
Dec 31, 2014---
Dec 31, 2013---
Dec 31, 2012---
Dec 31, 2011---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.